Geistlich Pharma AG
Geistlich Biomaterials is focused on the regeneration of bones and soft tissue
The Geistlich Group is a family-owned enterprise with activities including pharmaceuticals and biomaterials for medical applications, edible collagen foil for the meat processing industry, fats for cattle feed as well as adhesives and polymer powders for technical applications. The company was founded in 1851 as a glue factory. In 1986, Geistlich produced Bio-Oss®, the first natural bone substitution material.
Michael Peetz, Dr., Managing Director Geistlich Biomaterials
Katja Martin, Dr., Manager Clinical Research
Jean-François Clemence, Dr., Director Clinical Research
Bahnhofstrasse 40
6110 Wolhusen
Switzerland
Phone: +41-41-492-56-30
Fax: +41-41-492-56-39
Bio-Oss® is a natural bone mineral for bone regeneration with similarity to the structure of human bone. The stable, slowly resorbing matrix structure stabilises the blood coagulum, provides a good guide-rail function for the bone and has a long-term stability of the regenerated area. Other products include Bio-Gide®, Resor-Pin®, and Bio-Gide® Perio.
The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.
Related patents
- High Purity Bone Mineral
- Bone material and collagen combination for repair of injured joints
- Bone Fracture Fixation Plates
- Collagen Carrier of Therapeutic Genetic Material and Method
- Resorable Extracellular Matrix Containing Collagen I and Collagen II for Use in Cartilage Reconstructing Therapeutic Procedures, Skeleton Implant Therefor and Application of...
- Procede de Fabrication d'une Membrane de Collagene a Partir d'une Peau de Porc
- Bone Treatment Material
- Gemisch aus Knochenmaterial und Collagen zur Reparatur von Verletzten Gelenken
- Resorbable Extracellular Matrix for Reconstruction of Cartilage Tissue